Journal of Pediatric Neurology 2012; 10(02): 155-159
DOI: 10.3233/JPN-2012-0552
Georg Thieme Verlag KG Stuttgart – New York

A child with hemicrania continua phenotype responsive to botulinum toxin type-A

Manish Prasad
a   Department of Pediatric Neurology, Stirling Royal Infirmary, Stirling, UK
,
Sithara Ramdas
a   Department of Pediatric Neurology, Stirling Royal Infirmary, Stirling, UK
,
Ishaq Abu-Arafeh
a   Department of Pediatric Neurology, Stirling Royal Infirmary, Stirling, UK
› Institutsangaben

Verantwortlicher Herausgeber dieser Rubrik:
Weitere Informationen

Publikationsverlauf

28. August 2011

12. Dezember 2011

Publikationsdatum:
30. Juli 2015 (online)

Abstract

Our aim is to describe the difficulties in the diagnosis and treatment of a child with continuous unilateral headache. We present the case of a 12-year-old child who had a two year history of continuous dull pain behind the right ear with frequent episodes of severe sharp pain as well as ipsilateral color change on the cheek. We assess the role of international classification of headache disorders in establishing the diagnosis and we assess the treatment options. The international classification of headache disorders criteria for the diagnosis of hemicrania continua are, based on experience with adults and may not be adequate in children. The child had a very poor quality of life due to his illness and failed to respond to indomethacin among many other medications. However, he responded well to treatment with botulinum toxin type-A on two occasions. Childhood hemicrania continua may have a different phenotype than that in adults. Botulinum toxin type-A may be an option for treatment in some patients.